|Bid||0.00 x 1000|
|Ask||0.00 x 1100|
|Day's range||96.26 - 101.13|
|52-week range||96.25 - 206.36|
|Beta (5Y monthly)||0.72|
|PE ratio (TTM)||284.97|
|Earnings date||06 Nov 2023|
|Forward dividend & yield||0.64 (0.61%)|
|Ex-dividend date||30 Aug 2023|
|1y target est||152.50|
Penumbra and Mesa Labs are part of the Zacks Bull and Bear of the Day article.
Mesa diagnostics gains importance among big pharma so we want to watch this dip
Mesa Labs (MLAB) delivered earnings and revenue surprises of 5.99% and 2.32%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?